Litcius/Paper detail

<i>Fusobacterium nucleatum</i> and cancer

Tamar Alon‐Maimon, Ofer Mandelboim, Gilad Bachrach

2022Periodontology 2000183 citationsDOIOpen Access PDF

Abstract

Accumulating evidence demonstrates that the oral pathobiont Fusobacterium nucleatum is involved in the progression of an increasing number of tumors types. Thus far, the mechanisms underlying tumor exacerbation by F. nucleatum include the enhancement of proliferation, establishment of a tumor-promoting immune environment, induction of chemoresistance, and the activation of immune checkpoints. This review focuses on the mechanisms that mediate tumor-specific colonization by fusobacteria. Elucidating the mechanisms mediating fusobacterial tumor tropism and promotion might provide new insights for the development of novel approaches for tumor detection and treatment.

Topics & Concepts

Fusobacterium nucleatumMedicineFusobacteriumFusobacteriaMEDLINECancerDermatologyDentistryInternal medicineBacteroidesPeriodontitisPorphyromonas gingivalisBacteriaGeneticsLawPolitical scienceBiologyBacteroidetes16S ribosomal RNAGut microbiota and healthInfections and bacterial resistancePancreatitis Pathology and Treatment